|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-3-8
|
|
pubmed:abstractText |
The hepatitis C virus (HCV) genotype is the main predictor of response to interferon (IFN)-based therapies. HCV genotype 4 is spreading among European intravenous drug users, who are frequently coinfected with HIV. Information about treatment response in this subset of patients is scarce and conflicting results have been reported.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
167-70
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15751774-Adult,
pubmed-meshheading:15751774-Antiviral Agents,
pubmed-meshheading:15751774-Female,
pubmed-meshheading:15751774-Genotype,
pubmed-meshheading:15751774-HIV Infections,
pubmed-meshheading:15751774-Hepacivirus,
pubmed-meshheading:15751774-Hepatitis C, Chronic,
pubmed-meshheading:15751774-Humans,
pubmed-meshheading:15751774-Interferon Type I,
pubmed-meshheading:15751774-Male,
pubmed-meshheading:15751774-Recombinant Proteins,
pubmed-meshheading:15751774-Retrospective Studies,
pubmed-meshheading:15751774-Ribavirin,
pubmed-meshheading:15751774-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4.
|
|
pubmed:affiliation |
Service of Infectious Diseases, Hospital Carlos III, Madrid, Spain. vsoriano@dragonet.es
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
